Although AKT activity alterations have not frequently been reported in the DEN-induced mouse hepatocarcinogenesis model, abnormal activation of the PI3K/AKT signaling pathway is a hallmark of human HCC, and it has been associated with chronic liver injury [53]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.